文献速递急性肾损伤血液净化与透析

危重AKI患者早期启动RRT的长期临床结局

Long-Term Clinical Outcomes after Early Initiation of RRT in Critically Ill Patients with AKI.
PubMed 文献 · J Am Soc Nephrol · 2017-12-01

该研究将ELAIN试验随访从90天延长至1年,纳入230例危重AKI患者,比较早期(AKI 2期)与延迟(AKI 3期)启动RRT的长期结局。早期启动组主要肾脏不良事件复合终点、1年全因死亡率和未恢复肾功能比例均显著低于延迟组。

要点

  • 早期启动RRT显著降低1年主要肾脏不良事件复合终点(OR 0.23)。
  • 早期启动RRT组1年全因死亡率显著低于延迟组(50.2% vs 69.8%)。
  • 早期启动RRT组1年存活者未恢复肾功能比例显著更低(29.1% vs 63.9%)。

核心结论

  • 危重AKI患者早期启动RRT可显著减少1年主要肾脏不良事件、降低死亡率并促进肾功能恢复。

研究设计与样本

  • ELAIN试验延长随访至随机后1年,纳入230例(99.6%)危重AKI患者。
  • 早期启动组为AKI 2期启动RRT(111例),延迟启动组为AKI 3期启动RRT(119例)。

主要发现

  • 早期组72/111(64.9%)与延迟组106/119(89.1%)达到主要复合终点,OR 0.23(95%CI 0.11-0.45),P<0.001。
  • 1年全因死亡率早期组56/111(50.2%),延迟组83/119(69.8%),绝对差-19.6%(95%CI -32.0%至-7.2%),P<0.01。
  • 1年存活者未恢复肾功能早期组16/55(29.1%),延迟组23/36(63.9%),绝对差-34.8%(95%CI -54.6%至-15.0%),P=0.001。

关键数值与推荐

  • 主要终点为1年主要肾脏不良事件复合终点(持续性肾功能不全、透析依赖和死亡)。
  • 次要终点包括炎症标志物。

临床怎么用

  • 对危重AKI患者,在AKI 2期而非等待至3期启动RRT可能改善1年肾脏与生存结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Whether earlier initiation of RRT in critically ill patients with AKI can improve outcomes remains debated. We examined follow-up data from a large clinical trial to prospectively investigate the long-term outcomes associated with the timing of RRT initiation in such patients. We extended the follow-up of patients in the Early Versus Delayed Initiation of RRT in Critically Ill Patients with AKI (ELAIN) Trial from 90 days to 1 year after randomization for 230 (99.6%) patients. The primary outcome was a composite of major adverse kidney events (persistent renal dysfunction, dialysis dependence, and mortality) at 1 year. Secondary outcomes included inflammatory markers. Overall, 72 of 111 (64.9%) and 106 of 119 (89.1%) patients met the primary outcome in the early (stage 2 AKI) and delayed (stage 3 AKI) initiation groups, respectively (odds ratio [OR] with early initiation, 0.23; 95% confidence interval [95% CI], 0.11 to 0.45; P< 0.001). The early initiation group had a 1-year all-cause mortality rate (56 of 111 [50.2%]) significantly lower than that of the delayed initiation group (83 of 119 [69.8%]; absolute difference, -19.6%; 95% CI, -32.0% to -7.2%; P<0.01). After 1 year, 16 of 55 (29.1%) and 23 of 36 (63.9%) surviving patients in the early and delayed groups, respectively, failed to recover renal function (absolute difference, -34.8%; 95% CI, -54.6% to -15.0%; P=0.001). In conclusion, early initiation of RRT in these critically ill patients with AKI significantly reduced the occurrence of major adverse kidney events, reduced mortality, and enhanced renal recovery at 1 year.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Meersch M, Küllmar M, Schmidt C, et al. Long-Term Clinical Outcomes after Early Initiation of RRT in Critically Ill Patients with AKI. J Am Soc Nephrol. 2017. PMID: 29196304. doi:10.1681/ASN.2017060694

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。